Mandate

Investor Growth Capital investing in SciBase AB

August 15, 2006

Investor Growth Capital, SEB and CapMan are investing SEK 100 million in the medical technology company SciBase AB. The investment means that Investor Growth Capital, together with the former owners SEB Företagsinvest and CapMan will control 80% of the Swedish medical technology company.

Vinge acted as advisor to Investor Growth Capital and representatives from Vinge included Johan Winnerblad and Johan Larsson.

Related

Vinge has advised Rite Ventures in connection with sale of shares in Qliro AB (publ)

Vinge has advised Rite Ventures in connection with the sale of shares in Qliro AB (publ) to Svea Bank AB (publ).
November 19, 2026

Vinge advises Röko AB (publ) in connection with the establishment of its MTN programme

Vinge has advised Röko AB (publ) ("Röko") on the establishment of a medium-term note programme (the "MTN Programme") with a framework amount of SEK 5 billion.
November 13, 2026

Vinge advises Telavox on the sale of its Nordic customer base to Telia

Vinge has advised Telavox AB (“Telavox”) on the sale of Telavox’s Nordic customer base for business services to Telia Company AB (“Telia”). The customer base comprises approximately 24,000 business customers and 325,000 end users in Sweden, Denmark, Finland, and Norway. The purchase price amounts to SEK 3.8 billion plus a potential additional earn-out.
November 13, 2026